AZD1080是有效的、口服的、可选择性透过大脑的GSK3抑制剂。AZD1080通过与ATP口袋结合来抑制GSK3β，作用于重组人GSK3α/β的K_i值为6.9 nM和31 nM。AZD1080还能抑制tau蛋白的磷酸化，IC₅₀值为324 nM。

参考文献

1.Georgievska B, et al. AZD1080, a novel GSK3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans. J Neurochem. 2013;125(3):446-56.

2.Hu S, et al. Phosphorylation of Tau and α-Synuclein Induced Neurodegeneration in MPTP Mouse Model of Parkinson’s Disease. Neuropsychiatric Disease and Treatment. 2020;16:651.

冰袋运输。粉末直接保存于-20℃，有效期2年。建议分装后-20℃避光保存，避免反复冻融。